Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,061 | -18,206 | -12,124 | -10,432 | -5,499 |
| Depreciation Amortization | 525 | 1,998 | 1,468 | 976 | 484 |
| Accounts receivable | 282 | -919 | 141 | 438 | 400 |
| Other Working Capital | -79 | -421 | 414 | 115 | 428 |
| Other Operating Activity | 3,045 | 2,879 | 204 | -168 | -193 |
| Operating Cash Flow | $-5,288 | $-14,669 | $-9,899 | $-9,070 | $-4,380 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -124 | -9,447 | -408 | -1,847 | 159 |
| PPE Investments | -195 | -1,071 | -894 | -573 | -267 |
| Purchase Sale Intangibles | -95 | -397 | -277 | -198 | -121 |
| Other Investing Activity | -95 | -397 | -277 | -198 | -121 |
| Investing Cash Flow | $-414 | $-10,915 | $-1,578 | $-2,618 | $-230 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,971 | 43,527 | 22,379 | 22,379 | 22,312 |
| Financing Cash Flow | $7,971 | $43,527 | $22,379 | $22,379 | $22,312 |
| Beginning Cash Position | 34,598 | 16,655 | 16,655 | 16,655 | 16,655 |
| End Cash Position | 36,867 | 34,598 | 27,557 | 27,346 | 34,357 |
| Net Cash Flow | $2,270 | $17,943 | $10,902 | $10,691 | $17,702 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,288 | -14,669 | -9,899 | -9,070 | -4,380 |
| Capital Expenditure | -195 | -1,071 | -894 | -573 | -267 |
| Free Cash Flow | -5,483 | -15,740 | -10,793 | -9,644 | -4,647 |